Latest News
1.15.10 ASDx Biosystems establishes collaboration with MicroArrays Inc. for development of a multiplexed luminescent  immunoassay detection platform.

10.22.09

Biosystems presents results of high sensitivity assay for the detection of Botulinum toxins at the Interagency Botulism Research Coordinating  Committee (IBRCC) held in Washington DC.


10/1/09

ASDx Biosystems is awarded US Department of Homeland Security contract to expand development of an antigen detection platform in collaboration with the Center for Disease Control.


9/1/09 ASDx Biosystems establishes collaboration with Dr. Larry Stanker of the USDA ARS Western Regional Research Center for  development of botulinum luminescent immunoassays.
ASDx Biosystems specializes in the development of immunoassays for environmental agents, foodborne pathogens, infectious diseases and oncology biomarkers using luminescence detection technologies and dedicated luminometer instrument systems.

The company and its team of international experts are focused on integrating, validating and providing customers with the most advanced antibody, detection reagent and instrument technologies available for complete luminescence immunoassay systems.

ASDx Biosystems, Inc.
5500 Central Avenue, Suite 240 | Boulder, CO 80301
303.684.6704 (o) | 303.684.6724 (f)
email us | terms + privacy policy

copyright 2009-2010 asdx biosystems, inc. all rights reserved